1. Introduction {#sec1}
===============

Chronic obstructive pulmonary disease (COPD) is a persistent disease with recurrent daily symptoms. Despite available drug treatments such as bronchodilators and steroids, 20--43% of people with COPD also use complementary therapies, including Chinese herbal medicine (CHM), to alleviate their symptoms \[[@B1], [@B2]\]. The frequent use of CHM by COPD patients may be underpinned by their belief that herbal medicines are safe \[[@B1], [@B3]\]. Patients taking complementary therapies felt that these therapies did not have risks because of their "naturalness" \[[@B1]\].

CHM appears to have clinically beneficial effects with very low risk of adverse events. Recent systematic reviews demonstrated that CHM improved lung function \[[@B4]\] and quality of life \[[@B5]\]. While many of the studies included in these reviews did not report adverse events (AEs), a number of studies included information concerning minor events. Therefore, these authors concluded that CHM was overall well tolerated by COPD patients \[[@B4], [@B5]\].

Without specific reference to COPD, one prospective study on general safety of a range of CHM interventions over a four-week period showed that 14% of patients reported an AE which was associated with CHM \[[@B6]\]. The most common AE was diarrhoea (4.2 events per 100 patients over 4 weeks). Hong Kong Hospital data revealed that, in an eight-month period, 0.2% of admissions were associated with AE from CHM \[[@B7]\]. The AEs were mostly minor; however, some were severe. Several reviews of AEs associated with CHMs have described the nature of the AE, but not the number of events \[[@B3], [@B8]--[@B10]\], often due to omissions in included studies. Finally, one study reported one adverse event per 633 consultations with a CM practitioner (for either CHM treatment or acupuncture) \[[@B11]\].

Due to the wide ranging CHM formulae used for COPD and the generic term "Chinese herbal medicine" not commonly used, combined with variability in publication keywords, it is difficult to identify relevant studies through electronic database searching. To date, there has been no specific evaluation of the safety of CHM for people with COPD based on clinical research evidence. Therefore, we systematically reviewed AEs reported in clinical studies of CHM for COPD. This review describes the incidence of AEs including nature, severity, and relationship with CHM treatment and was undertaken as part of a broader review of the evidence of efficacy (reported elsewhere).

2. Materials and Methods {#sec2}
========================

The search strategy was guided by the Cochrane Airways Group methodology \[[@B12]\]. Nine databases were searched from inception to May 2013 (English: PubMed, Embase, CINAHL, AMED, and CENTRAL; Chinese: CBM, CNKI, CQVIP, and Wanfang Data). For the broader review that evaluated CHM efficacy for treating COPD, studies were included if they used CHM alone or combined with pharmacotherapy compared to pharmacotherapy, placebo, or no treatment. All forms of CHM were included, such as oral, intravenous, and intramuscular. Studies were eligible if they reported on adverse events in addition to any one of the following outcomes: lung function (FEV~1~, FVC), symptom severity (dyspnoea scales mMRC scale, Borg scale, and DVAS), exercise capacity (6 MWT), arterial blood gases (PaO~2~, PaCO~2~), COPD exacerbations, BODE index, or effective rate. Controlled clinical trials and noncontrolled studies published in English and Chinese were included. Studies which did not report the number of people randomised to the treatment and control groups (for controlled studies) were excluded.

The title and abstract of retrieved citations were screened for eligibility, and full text was retrieved where necessary. Eligibility assessment was confirmed by a second person. Study characteristics and AE data were extracted into a predefined form, with double-data extraction and consistency checking to ensure accuracy of the data. Studies which did not report on AEs were excluded from further analysis. Items relating to AEs included nature of AE and number of events, severity, and author-assigned causality, how the AE was managed, and the outcome. We used only the author-assigned causality (if reported) to avoid introducing bias, as we deemed it unlikely that sufficient information would be reported in the original publications to determine causality. For controlled studies, AEs were described according to group allocation or separately if group allocation was not specified by the study author. Where two events were reported together, for example, nausea and headache, these were considered as one incident for the purposes of this review.

The rate of AEs was calculated overall and according to CHM or control groups by dividing the number of events by the number of participants, expressed as a percentage. Similar AEs were grouped to allow for reporting of events by broad category. Analysis of time to event and multiple events per participant were planned but can not be performed due to insufficient details.

3. Results {#sec3}
==========

One hundred and fifty-two (152) of the 609 identified studies reported on AEs (occurrence or absence) (see [Figure 1](#fig1){ref-type="fig"}). The majority of studies were RCTs (144 studies), while two were nonrandomised controlled trials and six were noncontrolled studies. A total of 11,999 participants were included in this analysis, with 6,261 receiving treatment with CHM and 5,676 people allocated to control groups. The age of participants ranged from 18 to 92 years, and the median of mean age was 65.6 years. Duration of treatment ranged from three days to one year, with a median duration of two weeks. The most common CHM was*Tan re qing* injection (27 studies).

Adverse events occurred in 47 studies (involving 4,057 participants) \[[@B13]--[@B59]\] (see [Table 1](#tab1){ref-type="table"}). A total of 207 events were reported (11,999 participants, 1.7%). In the controlled studies, 84 events occurred in those who received CHM intervention (5,909 participants, 1.4%) and 102 events in those who were allocated to the control groups (5,676, 1.8%). Nausea was the most frequently reported AE in both CHM and control groups (occurring in 28 cases and 19 cases, resp.). The vast majority of nausea AEs occurred in people with acute exacerbation of COPD where CHM was combined with pharmacotherapy. Other frequently reported AEs included abdominal discomfort (13 cases in CHM, 3 cases in control), dry mouth (7 cases in CHM, 9 cases in control), and dizziness (4 cases in CHM, 10 cases in control).

For analysis, studies were grouped according to intervention categories: (1) CHM alone or (2) CHM combined with pharmacotherapy and by study design: (1) controlled studies and (2) noncontrolled studies. Events were categorised into three broad groups: gastrointestinal events, dermatological events, and miscellaneous events (see [Table 2](#tab2){ref-type="table"}). The CHM formulae and ingredients in studies where AEs occurred in the CHM groups are described in [Table 3](#tab3){ref-type="table"}.

3.1. Controlled Studies {#sec3.1}
-----------------------

### 3.1.1. CHM Alone {#sec3.1.1}

Eight studies compared CHM to controls and six reported the occurrence of AEs \[[@B39], [@B40], [@B44], [@B48], [@B50], [@B58]\]. Two studies reported that no events occurred \[[@B60], [@B61]\]. CHM was compared with placebo \[[@B44], [@B60]\], no treatment \[[@B58]\], or pharmacotherapy \[[@B39], [@B40], [@B48], [@B50], [@B61]\]. Twenty-nine (29) AEs were reported in the six studies. Thirteen of these AEs occurred in the treatment groups and 16 events in the control groups.

The number of gastrointestinal AEs was lower in those who received CHM compared with controls (2 AEs versus 6 AEs) but similar for miscellaneous AEs (11 AEs versus 10 AEs) (see [Table 2](#tab2){ref-type="table"}). No dermatological AEs were reported in both the CHM and comparator groups. The most frequently reported event in the CHM groups was shivering/shaking hands (3 events), while bloating was the most frequent AE in the comparator groups (3 events). In studies which described the severity of AEs, all were reported as mild with the exception of three infections which were judged as severe and lead to patient death. One death occurred in the treatment group but was deemed unlikely to be related to treatment and two in the control group of the same study \[[@B58]\]. In one study that evaluated*Mai men dong tang* (*Bakumondoto*) two cases of elevated alkaline phosphatase (ALP) were considered possibly related to treatment; however, retest was not performed and a full exploration of causality could not be determined \[[@B39]\]. To manage AEs, study investigators changed the CHM dose \[[@B50]\], prescribed other drugs \[[@B48]\], continued treatment as allocated \[[@B48], [@B50]\], or did not administer treatment \[[@B40]\], or the patients withdrew \[[@B58]\].

### 3.1.2. CHM Plus Pharmacotherapy {#sec3.1.2}

One hundred and thirty-eight (138) studies combined CHM with pharmacotherapy, and 37 of these reported the occurrence of 167 AEs \[[@B13]--[@B30], [@B32]--[@B34], [@B36]--[@B38], [@B41]--[@B43], [@B45]--[@B47], [@B49], [@B51]--[@B54], [@B56], [@B57]\]. In the intervention group, CHM was given with the same pharmacotherapy as the control group. Eighteen studies did not specify the pharmacotherapy used \[[@B13]--[@B16], [@B19], [@B20], [@B23], [@B25], [@B26], [@B29], [@B33], [@B34], [@B38], [@B47], [@B49], [@B51], [@B53], [@B54]\]. Antibiotics were used in 15 studies, methylxanthines in 14 studies, mucolytic agents in seven studies, bronchodilators and steroids in three studies each, and combined bronchodilator/inhaled corticosteroid in one study.

Fewer adverse events were reported in those who received CHM plus pharmacotherapy (71 events) compared with the pharmacotherapy alone (86 events). For a small number of AEs, the group allocation was not specified (10 events).

Adverse events were analysed according to the nature of the event (see [Table 2](#tab2){ref-type="table"}). The number of gastrointestinal adverse events was greater in CHM plus pharmacotherapy group than pharmacotherapy alone (35 versus 26 events), while the reverse was found for miscellaneous AEs (31 versus 48, resp.). Nausea was the most frequently reported AE, occurring in 27 events in the CHM plus pharmacotherapy group and 18 events in the pharmacotherapy alone group. Few dermatological events were reported and were similar between groups (10 in CHM plus pharmacotherapy, seven in pharmacotherapy alone). Intravenous injection with Tan re qingcombined with pharmacotherapy was associated with all the dermatological events in the treatment group. A broad range of other AEs were seen. Other frequently reported AEs were dry mouth/throat (5 cases in the treatment groups and 9 cases in the control groups) and dizziness (3 cases in the treatment groups and 6 cases in the control groups).

In studies where the severity of the AE was reported, all events were described as mild. Sixteen AEs were described as being probably related to CHM plus pharmacotherapy interventions \[[@B18], [@B21], [@B24], [@B28], [@B33], [@B37], [@B38], [@B41], [@B43], [@B46], [@B52]\], five events were possibly related to treatment \[[@B29]\], and one was unlikely to be related to treatment \[[@B22]\]. Nine reports of AEs in the pharmacotherapy group were considered probably related to treatment \[[@B18], [@B28], [@B37], [@B38], [@B43], [@B46]\] and five possibly related to treatment \[[@B29]\]. Management of AEs was reported in most studies and subsequently all the events resolved. Management included dosage change for CHM \[[@B15], [@B33], [@B46]\], prescription of other drugs and/or hospital admission \[[@B15], [@B18], [@B20], [@B24], [@B26], [@B28], [@B41], [@B43], [@B52]\], and no treatment \[[@B20], [@B22]\], and in 11 studies the AE was able to be tolerated whilst continuing treatment \[[@B14], [@B16], [@B23], [@B25], [@B30], [@B36]--[@B38], [@B42], [@B54], [@B56]\].

3.2. Noncontrolled Studies {#sec3.2}
--------------------------

Six case series report on AEs \[[@B31], [@B35], [@B55], [@B59], [@B62], [@B63]\]. Adverse events occurred in four studies, two where CHM was used alone \[[@B55], [@B59]\] and two where CHM was combined with pharmacotherapy \[[@B31], [@B35]\]. Nine AEs were reported in those who received CHM alone, and two events occurred where CHM was combined with pharmacotherapy. Exacerbation of COPD was the most common AE in the noncontrolled studies (5 events). Exacerbations were managed with antibiotics \[[@B55]\]. Other AEs included vomiting (2 events) \[[@B59]\], and one case each included nausea \[[@B59]\], headache and dizziness \[[@B59]\], abdominal discomfort and nausea \[[@B35]\], and patient death (reason not given) \[[@B31]\]. None of the studies reported the severity of the AE or assigned causality. The one participant who reported abdominal discomfort and nausea continued treatment \[[@B35]\], and the headache and dizziness in one participant resolved without intervention \[[@B59]\].

4. Discussion {#sec4}
=============

Overall, the rate of AEs in clinical studies of CHM for COPD was low (1.7%). The rate of AEs in participants who received CHM intervention was slightly lower than control groups, 1.4% versus 1.8%. This result fell well within the range of minimal risk for minor complications (0.1% to 10%) suggested by MacPherson et al. \[[@B64]\]. Where described, the majority of AEs were mild in severity. CHM appears to be well tolerated by patients with COPD.

Nausea was the most common AE in both the treatment groups and control groups but was higher amongst those who received CHM. The majority of nausea AEs occurred in people with an acute exacerbation of COPD. It is difficult to determine whether this is related to exacerbation, the CHMs, or the pharmacotherapy administered concurrently. Whilst the number of AEs which included nausea was higher in those who received CHM, this was within the range for minimal risk \[[@B64]\] and overall the data shows that CHM in combination with pharmacotherapy does not pose any additional risks for people with acute exacerbations of COPD. The data shows no clusters of particular events. A causal relationship to treatments was not evident and the AEs may reflect general fluctuations in the patients\' conditions.

Many of the pharmacotherapies used in included studies have established safety profiles and known AEs. For example, bronchodilators can cause tremor, tachycardia, headaches, nausea, palpitations, hypokalaemia, and dry mouth, and corticosteroids can cause pneumonia, oral candidiasis, and skin bruising \[[@B65]\]. Among studies of CHM plus pharmacotherapy versus pharmacotherapy alone the number of AEs was lower amongst those who received CHM. In clinical practice, the choice of CHM can be influenced by the known safety profile of particular pharmacotherapies, with herbs added to address known side effects. The finding from this review suggests that CHM may reduce the number of AEs in people with COPD, although further research is needed to confirm this finding as the differences seen were small.

People with COPD often have comorbidities requiring polydrug therapy, which may increase the potential for herb-drug interactions. Indeed, there is significant potential for adverse drug reactions in elderly people with complex and chronic health conditions such as COPD and asthma \[[@B66]\]. Elderly people with COPD who are taking CHM in addition to prescribed medications should be monitored for the emergence of new signs or symptoms and should be reviewed regularly.

The data presented in this review is important because there are no existing reviews of clinical studies on the safety of CHM for COPD. While population and practitioner surveys may be more reflective of clinical practice, AEs reported in population surveys may differ from those in clinical studies because of known controllable risks associated with CHM. These include misidentification of herbal medicines, substitution, lack of standardisation, contamination, and adulteration, as well as some herbal ingredients not being listed on the product labels \[[@B67], [@B68]\]. In the clinical trial setting, the herbal medicine(s) is more likely to be controlled for these issues and any subsequent AEs can be better understood in the context of specific causality rather than poor manufacturing or handling.

The challenges of conducting systematic reviews of CHM have been described by White \[[@B69]\]. This review found a lower rate of AEs than that of MacPherson and Liu \[[@B6]\]. Few systematic reviews have evaluated the safety of CHM, and none have focused on patients with COPD. This may in part be due to the many and varied herbal formulae used in clinical trials and variation in publication keywords which limits electronic database searching. Further, the incidence of AEs is challenging to calculate as it requires adequate reporting of AEs in clinical studies (e.g., number and nature of events and authors definition of AE), information on the number of consultations, and whether the CHM was changed during the course of treatment. Additionally, some studies only provided limited and vague statements about AEs, such as "there were no AEs" or "CHM was safe." Therefore the actual frequency of AEs may be underestimated.

Reporting of details of AEs in studies included in this review was limited largely to the nature and number of AEs, with scant details on severity, causality, management, and outcome. As AE data can be influenced by the manner in which it is collected \[[@B70]\], future clinical studies should describe the process for collection of safety data. Further, AE data in future clinical studies of CHM for COPD should be reported in accordance with the CONSORT extension for reporting of harms in randomised trials \[[@B71]\].

Finally, the diversity of CHM formulae and individual herbs used in included studies did not allow for greater exploration of AEs by individual formula (with the exception of Tan re qing injection) or by individual herb. In CHM formula with multiple herb ingredients, it is difficult to attribute AEs to one herb or the synergistic actions of all herb ingredients. Thus, the findings of this review are limited to describing the potential for an AE when any CHM formula is used. The selection of CHM formula for people with COPD should consider relevant available safety data and the concomitant medications being used by the patient.

5. Conclusion {#sec5}
=============

Overall, CHM is well tolerated by patients with COPD. The rate of AEs is low, minor, and self-resolving and was slightly less than that of pharmacotherapy, placebo, and no treatment. The most common AE was nausea, which was seen when CHM was combined with pharmacotherapy for acute exacerbations of COPD. In addition, CHM appeared to be safe when taken in combination with pharmacotherapies. Future research should provide greater details relating to AEs in order to more accurately inform clinical practice.
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###### 

Characteristics of studies reporting adverse events.

  Study author, year   Study design   Stage of COPD   Comparison   Sample size   Number randomised to treatment group/control group   CHM intervention; administration                                                                 Cointervention/comparator
  -------------------- -------------- --------------- ------------ ------------- ---------------------------------------------------- ------------------------------------------------------------------------------------------------ ----------------------------------------------------
  Che HZ, 2005         RCT            Stable          2            50            25/25                                                Zhi ke qing fei liquid, oral                                                                     Pharmacotherapy
  Chen R, 2005         RCT            AECOPD          2            66            36/30                                                Jin shui bao capsule, oral                                                                       Pharmacotherapy
  Cui FS, 2013         RCT            AECOPD          2            69            35/34                                                Ma xing shi gan tang, oral                                                                       Multipharmacotherapies
  Dong GB, 2008        RCT            AECOPD          2            240           120/120                                              Xi xin nao, IV                                                                                   Pharmacotherapy
  Fu ZY, 2008          RCT            Stable          2            60            30/30                                                Chen xia liu jun zi tang + San zi yang qin tang (modified), oral                                 Methylxanthines
  Gong GL, 2008        RCT            AECOPD          2            96            53/43                                                Tan re qing, IV                                                                                  Antibiotics plus mucolytics
  Guo LX, 2005         RCT            AECOPD          2            60            30/30                                                Tan re qing, IV                                                                                  Antibiotics plus methylxanthines plus mucolytic
  Guo YR, 2011         RCT            AECOPD          2            60            30/30                                                Huang qi tang, oral                                                                              Multipharmacotherapies
  Han GL, 2011         RCT            AECOPD          2            68            37/31                                                Hua zhuo qu yu tang, oral                                                                        Pharmacotherapy
  Hu Y, 2010           RCT            AECOPD          2            94            34/28                                                Tan re qing, inhaled                                                                             Antibiotics plus methylxanthines plus mucolytic
  Hua ZQ, 2013         RCT            AECOPD          2            98            50/48                                                Yi qi qing fei tang, oral                                                                        Pharmacotherapy
  Huang B, 2006        RCT            AECOPD          2            60            30/30                                                Tan re qing, IV                                                                                  Multipharmacotherapies
  Huang DH, 2005       RCT            Stable          2            63            32/31                                                Yu ping feng ke li + Bai ling capsule + Jian pi yi fei chong ji, oral                            Pharmacotherapy
  Ji, 2003             CCT            Stable          2            19            10/9                                                 CHM formula (unnamed), oral                                                                      Pharmacotherapy
  Li L, 2011           RCT            Stable          2            70            35/35                                                Shen ge jiao nang, oral                                                                          Methylxanthines plus placebo
  Li DL, 2009          RCT            AECOPD          2            60            30/30                                                Xuan bai chen qi tang, oral                                                                      Antibiotics plus methylxanthines plus mucolytic
  Li FY, 2009          RCT            AECOPD          2            96            64/32                                                Tan re qing, IV                                                                                  Antibiotics plus mucolytics
  Li PW, 2010          CS             NS              4            68            NA                                                   Wen qing di tan yin (modified), oral                                                             Pharmacotherapy
  Li SY, 2012          RCT            Stable          2            352           176/176                                              Bu fei jian pi or Bu fei yi shen or Yi qi zi shen, oral                                          Pharmacotherapy
  Liang AL, 2009       RCT            Stable          2            60            30/30                                                CHM formula (unnamed), oral                                                                      Salmeterol/fluticasone and methylxanthines
  Liu JB, 2012         RCT            AECOPD          2            62            31/31                                                Tan re qing, IV                                                                                  Pharmacotherapy
  Liu W, 2011          RCT            AECOPD          2            62            32/30                                                Xie fei tang + Li pi bu shen tang (modified), oral                                               Pharmacotherapy
  Liu XJ, 2005         CS             AECOPD          4            126           NA                                                   Tan re qing, IV                                                                                  Pharmacotherapy
  Liu YQ, 2006         RCT            AECOPD          2            83            43/40                                                Jin shui bao jiao nang, oral                                                                     Antibiotics plus methylxanthines plus steroids
  Ma XC, 2009          RCT            AECOPD          2            112           60/52                                                Tan re qing, IV                                                                                  Multipharmacotherapies
  Ming ZQ, 2008        RCT            AECOPD          2            40            20/20                                                Xue bi jing, IV                                                                                  Pharmacotherapy
  Mukaida, 2011        RCT            Stable          1            24            13/11                                                Mai men dong tang (Bakumondoto), oral                                                            Pharmacotherapy
  Ou L, 2012           CCT            AECOPD          1            82            41/41                                                Jin kui shen qi pill + Ma xing shi gan formula + Xiao qing long formula + Bu fei formula, oral   Multipharmacotherapies
  Peng WG, 2008        RCT            AECOPD          2            87            44/43                                                Tan re qing, IV                                                                                  Antibiotics plus methylxanthines plus mucolytic
  Shen YD, 2010        RCT            Stable          2            81            32/49                                                Gu ben ke chuan pill, oral                                                                       Ipratropium bromide plus routine care
  Tong WN, 2012        RCT            Stable          2            82            42/40                                                Xiao ke chuan jiao nang, oral                                                                    Bronchodilator
  Wu, 2011             RCT            Stable          1            263           178/85                                               Jian pi yi fei II (modified), oral                                                               Placebo
  Xiong CW, 2011       RCT            AECOPD          2            112           56/56                                                Fu zheng hua tan qu yu tang (modified), oral                                                     Pharmacotherapy
  Yang XJ, 2006        RCT            AECOPD          2            50            25/25                                                Tan re qing, IV                                                                                  Antibiotics plus bronchodilator plus mucolytic
  Ye, 2010             RCT            Stable          1            90            45/45                                                Bu yuan tang, oral                                                                               Pharmacotherapy
  You BW, 2007         RCT            Stable          2            64            32/32                                                Yi fei he ji, oral                                                                               Methylxanthines plus a bronchodilator plus steroid
  Yuan YL, 2011        RCT            AECOPD          2            80            40/40                                                Sang bai pi tang (modified), oral                                                                Pharmacotherapy
  Zhai, 2012           RCT            Stable          1            140           70/70                                                Fu zheng qing tan hua yu, oral                                                                   Drug therapy
  Zhang, 2008          RCT            Stable          1            73            38/35                                                Liu jun zi pill, oral                                                                            No treatment
  Zhang LH, 2011       RCT            AECOPD          2            80            40/40                                                Su zi jiang qi tang, oral                                                                        Antibiotics plus methylxanthines plus mucolytic
  Zhang Y, 2004        RCT            AECOPD          2            60            30/30                                                Tan re qing, IV                                                                                  Antibiotics plus methylxanthines plus mucolytic
  Zhang YF, 2010       CS             NS              3            45            NA                                                   Yang he tang (modified), oral                                                                    NA
  Zhao W, 2012         RCT            AECOPD          2            62            31/31                                                CHM formula (unnamed), oral                                                                      Multidrug therapy
  Zheng H, 2012        RCT            AECOPD          2            60            30/30                                                CHM formula (unnamed), oral                                                                      Pharmacotherapy
  Zheng XG, 2003       CS             Stable          3            60            NA                                                   Yi xin kang tai jiao nang, oral                                                                  NA
  Zhong HW, 2010       RCT            Stable          2            87            44/43                                                Fei shu jiao nang, oral                                                                          Methylxanthines alone
  Zhou J, 2008         RCT            AECOPD          2            81            43/38                                                Tan re qing, IV                                                                                  Antibiotics plus methylxanthines plus mucolytic

AECOPD: acute exacerbation of COPD; CCT: controlled clinical trial; CHM: Chinese herbal medicine; CS: case series; I: intervention; IV: intravenous; NA: not applicable; NS: not specified; RCT: randomised controlled trial.

Comparison column: 1: CHM versus control; 2: CHM plus pharmacotherapy versus pharmacotherapy; 3: CHM (case series); 4: CHM plus pharmacotherapy (case series).

###### 

Summary of adverse events.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Intervention type                                                                                                                                             Group                                         Gastrointestinal events                       Dermatological events                            Miscellaneous events
  ------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------- --------------------------------------------- ------------------------------------------------ ------------------------------------------------
  Controlled trials                                                                                                                                                                                                                                                                                          

  CHM (*n* = 6) \[[@B39], [@B40], [@B44], [@B48], [@B50], [@B58]\]                                                                                              Treatment                                     **Total events: 2** \                         **None**                                         **Total events: 11** \
                                                                                                                                                                                                              Diarrhoea: 2                                                                                   Not specified: 5\
                                                                                                                                                                                                                                                                                                             Shivering/shaking hands: 3\
                                                                                                                                                                                                                                                                                                             Elevated alkaline phosphatase (ALP): 2\
                                                                                                                                                                                                                                                                                                             Infection: 1

  Control                                                                                                                                                       **Total: 6** \                                **None**                                      **Total: 10** \                                  
                                                                                                                                                                Nausea/bloating: 3\                                                                         Not specified: 3\                                
                                                                                                                                                                Bloating: 3                                                                                 Infection: 2\                                    
                                                                                                                                                                                                                                                            Insomnia: 1\                                     
                                                                                                                                                                                                                                                            Limb tremor: 1\                                  
                                                                                                                                                                                                                                                            Tachycardia: 1\                                  
                                                                                                                                                                                                                                                            Cerebrovascular accident: 1\                     
                                                                                                                                                                                                                                                            Heart failure: 1                                 

                                                                                                                                                                                                                                                                                                             

  CHM + pharmacotherapy (*n* = 38) \[[@B13]--[@B30], [@B32]--[@B34], [@B36]--[@B38], [@B41]--[@B43], [@B45]--[@B47], [@B49], [@B51]--[@B54], [@B56], [@B57]\]   Treatment                                     **Total: 33** \                               **Total: 10** \                                  **Total: 28** \
                                                                                                                                                                                                              Nausea and abdominal distension: 9\           Rash/red papules: 7\                             Dry mouth: 5\
                                                                                                                                                                                                              Nausea: 8\                                    Itching: 3                                       Exacerbation of COPD: 5\
                                                                                                                                                                                                              Nausea and vomiting: 6\                                                                        Dizziness: 3\
                                                                                                                                                                                                              Gastrointestinal reaction (unspecified): 4\                                                    Upper respiratory tract infection: 2\
                                                                                                                                                                                                              Nausea and diarrhoea: 2\                                                                       Dry mouth and abdominal distension: 2\
                                                                                                                                                                                                              Nausea and stomach upset: 2\                                                                   Acid regurgitation and chest distress: 2\
                                                                                                                                                                                                              Constipation: 1\                                                                               Nose injury (trauma due to breathing mask): 2\
                                                                                                                                                                                                              Abdominal distension: 1                                                                        Headache: 1\
                                                                                                                                                                                                                                                                                                             Hypertension: 1\
                                                                                                                                                                                                                                                                                                             Insomnia: 1\
                                                                                                                                                                                                                                                                                                             Irritability: 1\
                                                                                                                                                                                                                                                                                                             Palpitation: 1\
                                                                                                                                                                                                                                                                                                             Pulmonary encephalopathy: 1\
                                                                                                                                                                                                                                                                                                             Thirst: 1

  Control                                                                                                                                                       **Total: 26** \                               **Total: 7** \                                **Total: 53** \                                  
                                                                                                                                                                Nausea: 8\                                    Rash: 6\                                      Dry mouth/throat: 9\                             
                                                                                                                                                                Nausea and vomiting: 4\                       Blister: 1                                    Dizziness: 6\                                    
                                                                                                                                                                Nausea and dizziness: 4\                                                                    Upper respiratory tract infection: 6\            
                                                                                                                                                                Diarrhoea: 4\                                                                               Nose injury (trauma due to breathing mask): 4\   
                                                                                                                                                                Nausea and abdominal distension: 2\                                                         Palpitation: 4\                                  
                                                                                                                                                                Abdominal distension: 1\                                                                    Pulmonary encephalopathy: 3\                     
                                                                                                                                                                Loss of appetite: 1\                                                                        Irritability: 3\                                 
                                                                                                                                                                Constipation: 1\                                                                            Fungal infection: 3\                             
                                                                                                                                                                Stomach discomfort: 1                                                                       Exacerbation of COPD: 2\                         
                                                                                                                                                                                                                                                            Hypertension: 2\                                 
                                                                                                                                                                                                                                                            Leukocyte \<4 × 10^9^/L: 2\                      
                                                                                                                                                                                                                                                            Lung infection: 2\                               
                                                                                                                                                                                                                                                            Insomnia: 1\                                     
                                                                                                                                                                                                                                                            Black stool: 1\                                  
                                                                                                                                                                                                                                                            Allergy to antibiotics: 1\                       
                                                                                                                                                                                                                                                            Platelet \<100 × 10^9^/L: 1\                     
                                                                                                                                                                                                                                                            Sinus tachycardia: 1\                            
                                                                                                                                                                                                                                                            Thirst: 1\                                       
                                                                                                                                                                                                                                                            Not specified: 1                                 

  Group not specified                                                                                                                                           **Total: 10** \                               **None**                                      **None**                                         
                                                                                                                                                                Abdominal distension: 5\                                                                                                                     
                                                                                                                                                                Gastrointestinal reaction (unspecified): 3\                                                                                                  
                                                                                                                                                                Diarrhoea: 2                                                                                                                                 

                                                                                                                                                                                                                                                                                                             

  Case series                                                                                                                                                                                                                                                                                                

  CHM (*n* = 2) \[[@B55], [@B59]\]                                                                                                                              NA                                            **Total: 3** \                                **None**                                         **Total: 6** \
                                                                                                                                                                                                              Vomiting: 2\                                                                                   Exacerbation of COPD: 5\
                                                                                                                                                                                                              Nausea: 1                                                                                      Headache and dizziness: 1

                                                                                                                                                                                                                                                                                                             

  CHM + pharmacotherapy (*n* = 2) \[[@B31], [@B35]\]                                                                                                            NA                                            **Total: 1** \                                **None**                                         **Total: 1** \
                                                                                                                                                                                                              Abdominal discomfort and nausea: 1                                                             Death (cause unknown): 1
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

CHM formula and ingredients of studies with adverse events in treatment groups.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  CHM intervention; route of administration                                                        Herbal ingredients                                                                                                                                                                                                                                                                                                                                                                                                      References
  ------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------
  Bu fei jian pi or Bu fei yi shen or Yi qi zi shen, oral                                          Bu fei jian pi: huang qi, dang shen, bai zhu, fu ling, and chuan bei mu; Bu fei yi shen: ren shen, huang qi, gou qi zi, shan zhu yu, and yin yang huo; Yi qi zi shen: ren shen, huang jing, shu di huang, mai dong, and wu wei zi                                                                                                                                                                                       \[[@B29]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Chen xia liu jun zi tang + San zi yang qin tang (modified), oral                                 Dang shen, bai zhu, fu ling, chen pi, fa xia, su zi, lai fu zi, bai jie zi, tao ren, zhe bei mu, bei xing, hai ge qiao, and gan cao                                                                                                                                                                                                                                                                                     \[[@B17]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  CHM formula (unnamed), oral                                                                      Ma huang, bai guo, sang bai pi, zhe bei mu, gua lou, huang qin, su zi, zi he che, and ge jie                                                                                                                                                                                                                                                                                                                            \[[@B54]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  CHM formula (unnamed), oral                                                                      Fa ban xia, fu ling, chuan xiong, chao gu ya, chao mai ya, bai he, shan yao, sha shen, fo shou, shan zha, jin fei cao, and zhe bei mu                                                                                                                                                                                                                                                                                   \[[@B26]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Fei shu jiao nang, oral                                                                          Hong shen, ge jie, san qi, chuan bei mu, di long, chuan xiong, and gan cao                                                                                                                                                                                                                                                                                                                                              \[[@B56]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Fu zheng hua tan qu yu tang (modified), oral                                                     Zhi fu zi, bu gu zi, ting li zi, chuan xiong, and yu jin                                                                                                                                                                                                                                                                                                                                                                \[[@B45]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Fu zheng qing tan hua yu, oral                                                                   Sheng shai shen/ren shen, ha jie, wu wei zi, xing ren, gua lou, xie bai, dan shen, tao ren, and mao dong qing                                                                                                                                                                                                                                                                                                           \[[@B50]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Gu ben ke chuan pill, oral                                                                       NS                                                                                                                                                                                                                                                                                                                                                                                                                      \[[@B42]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Hua zhuo qu yu tang, oral                                                                        Chi shao, dan shen, tao ren, hong hua, gua lou, su mu, zi su zi, zhe bei mu, fu ling, kuan dong hua, yu xing cao, and gan cao                                                                                                                                                                                                                                                                                           \[[@B21]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Huang qi tang, oral                                                                              Huang qi, dang shen, bai zhu, gua lou, xing ren, tao ren, chuan xiong, dang gui, chen pi, and huang qin                                                                                                                                                                                                                                                                                                                 \[[@B20]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Jian pi yi fei II (modified), oral                                                               Dang shen, bai zhu, suo yang, and tao ren                                                                                                                                                                                                                                                                                                                                                                               \[[@B44]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Jin kui shen qi pill + Ma xing shi gan formula + Xiao qing long formula + Bu fei formula, oral   Jin kui shen qi pill: shu di huang, shan zhu yu, shan yao, shu fu zi, gui zhi, bu gu zhi, fu ling, tao ren, ze xie, and wu wei zi\                                                                                                                                                                                                                                                                                      \[[@B40]\]
                                                                                                   Ma xing shi gan formula: ma huang, xing ren, huang qin, jie geng, sheng shi gao, yu xing cao, jin yin hua, lian qiao, zhe bei, tao ren, and gan cao\                                                                                                                                                                                                                                                                    
                                                                                                   Xiao qing long formula: gui zhi, bai shao, gan jiang, ma huang, ban xia, zhe bei, xi xin, chuan xiong, wu wei zi, and gan cao\                                                                                                                                                                                                                                                                                          
                                                                                                   Bu fei formula: shu di, huang qi, dang shen, sang bai pi, zi yuan, kuan dong hua, qian hu, chen pi, wu wei zi, dan shen, su zi, and bai jie zi                                                                                                                                                                                                                                                                          

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Jin shui bao jiao nang, oral                                                                     Jin shui bao jiao nang                                                                                                                                                                                                                                                                                                                                                                                                  \[[@B14], [@B36]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Liu jun zi pill, oral                                                                            NS                                                                                                                                                                                                                                                                                                                                                                                                                      \[[@B58]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Ma xing shi gan tang, oral                                                                       Ma huang, xing ren, shi gao, gan cao, lai fu zi, ting li zi, fu ling, jv hong, zhu ru, shi chang pu, yu jin, gui zhi, fu ling, bai zhu, zhu ling, and ze xie                                                                                                                                                                                                                                                            \[[@B15]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Mai men dong tang (Bakumondoto), oral                                                            Mai men dong, ban xia, gu ya, da zao, ren shen, and gan cao                                                                                                                                                                                                                                                                                                                                                             \[[@B39]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Shen ge jiao nang, oral                                                                          Ren shen, chuan bei, zi he che, and zhi ge jie                                                                                                                                                                                                                                                                                                                                                                          \[[@B30]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Tan re qing, inhaled                                                                             NS                                                                                                                                                                                                                                                                                                                                                                                                                      \[[@B22]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Tan re qing, IV                                                                                  Huang qin, jin yin hua, lian qiao, xiong dan fen, and shan yang jiao                                                                                                                                                                                                                                                                                                                                                    \[[@B18], [@B19], [@B24], [@B28], [@B33], [@B35], [@B37], [@B41], [@B46], [@B52]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Wen qing di tan yin (modified), oral                                                             Jiang ban xia, bei xi xin, wu wei zi, gan jiang, ting li zi, fu ling, and wang jiang nan. If yin deficiency, add sha shen, mai dong; if phlegm heat, add sang bai pi, gua lou pi                                                                                                                                                                                                                                        \[[@B31]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Xi xin nao, IV                                                                                   NS                                                                                                                                                                                                                                                                                                                                                                                                                      \[[@B16]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Xiao ke chuan jiao nang, oral                                                                    Man shan hong                                                                                                                                                                                                                                                                                                                                                                                                           \[[@B43]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Xue bi jing, IV                                                                                  NS                                                                                                                                                                                                                                                                                                                                                                                                                      \[[@B38]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Yang he tang (modified), oral                                                                    Su di, su zi, rou gui, gan cao, zhi ma huang, lu jiao jiao, bai jie zi, fa xia, shu mu, chen pi, and pao jian. If with cough, add chuan bei, zhi zhi wan; if with phlegm, add gua lou ren, cao miao zi; if spleen qi deficiency, add dang shen, bai zhu; if blood stasis, add dan shen, tao ren, yi mu cao; if with heat, remove rou gui, lu jiao jiao, and su di and add sang bai pi, zhe bei, se gan, and huang qin   \[[@B59]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Yi qi qing fei tang, oral                                                                        Huang qi, dan shen, huang qin, bei mu, ban xia, jie geng, gua lou qiao, and yu xing cao                                                                                                                                                                                                                                                                                                                                 \[[@B23]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Yi xin kang tai jiao nang, oral                                                                  Tang gu te qian xian lian, duo xian xian gou zi, tang gu te da huang, and shuo yang                                                                                                                                                                                                                                                                                                                                     \[[@B55]\]

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Yu ping feng ke li + Bai ling capsule + Jian pi yi fei chong ji, oral                            Yu ping feng ke li: NS; Bai ling capsules: NS; Jian pi yi fei chong ji: ren shen, bai zhu, fu ling, mai dong, sang bai pi, and huang qi                                                                                                                                                                                                                                                                                 \[[@B25]\]
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

IV: intravenous; NS: not specified.

[^1]: Academic Editor: Chang-Gue Son
